Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Biosynex
ALBIOBiosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France. Address: 22 Boulevard SEbastien Brant, Illkirch-Graffenstaden, France, 67400
Analytics
Precio Objetivo de WallStreet
11.93 EURRelación P/E
–Rentabilidad por dividendo
–Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave ALBIO
Análisis de dividendos ALBIO
Aumento del dividendo durante 5 años
–Crecimiento continuo
1 AñoRatio de pago medio en 5 años
50 %Tendencia del payout ALBIO
Valoración de la acción ALBIO
Finanzas ALBIO
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |